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Conclusions: DW-MRI is useful in assessing response in MIBC. It may be 
a potential biomarker for predicting nCT sensitivity and guide 
selection for bladder sparing approaches but further work is needed.  
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GYNEACOLOGY AND HAEMATOLOGY  
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Purpose/Objective: Cancer cells exhibit increased glucose 
metabolism through an upregulation of glycolysis. Increased glycolysis 
may occur in response to hypoxia or in an oxygen-independent manner 
as a result of altered gene expression, both mediated via the HIF-1 
transcription factor. It has been shown that tumours with high levels 
of glycolysis, as indicated by high lactate concentration, are less 
responsive to radiotherapy. The goal of this pre-clinical study was to 
evaluate glycolytic targeting by HIF-1 inhibition as a strategy to 
enhance radiation response.  
Materials and Methods: Cervix (ME180) and hypopharynx (FaDu) 
xenograft tumours were grown in the hind leg of nude mice. Mice 
were placed in an environmental chamber for exposure to different 
oxygen conditions (20% or 7% inspired oxygen concentration for 3 
hours). HIF-1 inhibition was achieved by two methods: a doxycycline-
inducible HIF-1 negative mutant and lentiviral transfection of the HIF-
1 shRNA. Glycolysis was evaluated using ex-vivo quantitative bio-
luminescence microscopy of lactate concentration and distribution in 
tumour cryosections. Tumour hypoxic fraction was measured using EF5 
immunohistochemical staining. Growth delay of xenografts was 
studied following their irradiation with a single 20Gy fraction. 
Results: In air-breathing (20% oxygen) conditions, HIF-1 knockdown 
caused no significant difference in average lactate or EF5 levels or in 
tumour growth. Under conditions of hypoxia (7% oxygen), HIF-1 
inhibition produced a significant (p<0.05) reduction in average lactate 
levels compared to controls in both the ME180 and FaDu tumours (15.8 
to 12.4 μmol/g and 8.4 to 5 μmol/g respectively). The hypoxic 
fraction increased (p<0.05) with HIF-1 inhibition in both tumours 
(ME180: 0.09 to 0.13 and FaDu: 0.06 to 0.13). Tumours treated with a 
combination of HIF-1 knockdown and radiation had an increased 
growth delay compared to tumours treated with radiation alone 
(p<0.05). HIF-1 inhibition did not alter the growth of non-irradiated 
tumours.  
Conclusions: HIF-1 inhibition can reduce glycolysis and improve 
radiation response in hypoxic tumours despite an associated increase 
in the hypoxic fraction. The underlying molecular mechanisms require 
further investigation but the results suggest that HIF-1 inhibitors, by 
virtue of their effects on tumour metabolism, might be useful 
radiosensitizing agents. 
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Purpose/Objective: Diffusion-weighted magnetic resonance imaging 
(DWI) provides information about the movement of water molecules 
inside tissue. The clinical utility of DWI in gynecologic malignancies 
has steadily increased over recent years. The purpose of our study is 
to focus on the quantitative index of DWI—the Apparent Diffusion 
Coefficient (ADC) value, to investigate its role as a predictor of 
treatment response and to establish a correlation between baseline 
ADC value and outcome. 
Materials and Methods: A total of 20 patients (mean age 55.2 years) 
of squamous cell carcinoma cervix (FIGOStages IB through IIIB) who 
underwent radical chemoradiation and had a median follow up of 6 
months were included in the ADC analysis. Apparent Diffusion 
Coefficient of ten normal controls was assessed. MRI was performed 
pretreatment and 3 months after treatment on a 3T Siemens MRI unit. 
For calculation of ADC a b value of 500mm2/s was used. SPSS v 17.0 
was used for analysis. 
Results: The mean ADC of cervical carcinomas (0.76 ± 0.26 ×10-
3mm2/s) was significantly lower than normal cervix (1.45 ± 0.46×10-
3mm2/s) (P<0.001). The mean post treatment ADC values (1.40 +0.15 x 
10-3 mm2/s) at 3 months were also significantly (p<0.01) higher in 
responders (n = 17) and they remain disease free at 6 months. Mean 
post treatment ADC values were 1.05 + 0.25 x 10-3 mm2/s at 3 months 
in nonresponders. However, there was no statistically significant 
correlation seen between pre treatment mean ADC and FIGO stage, 
nodal disease or tumour volume.  
Conclusions: Baseline pretreatment ADC values are low in squamous 
cell carcinoma cervix and they show a significant change after radical 
chemoradiation in responders. Although our data is early and the 
patient numbers are small, there is indication that the absolute ADC 
value at 3 months post treatment can predict long term disease 
control and could help to identify a potential cut off value that may 
call for early clinical intervention in nonresponders.  
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Purpose/Objective: There is dearth of data on Quality of Life (QOL) in 
patients treated with Intensity Modulate Radiotherapy (IMRT) for 
cervical cancers. The present study was undertaken to quantify serial 
changes in QOL before and after postoperative IMRT. 
Materials and Methods: Patients undergoing adjuvant or salvage IMRT 
(50 Gy/25 #/ 5 wks with concurrent weekly cisplatin and vaginal 
brachytherapy) within clinical trials completed the EORTC QLQC30 
and cervix specific module (Cx-24) in EORTC validated vernacular 
language before, after, 3 and 6 months of completion of IMRT. Raw 
scores were calculated as per standard EORTC recommendations and 
final score was determined for each of the items using SPSS version 
20.0. Wilcoxon signed rank test was applied for comparison between 
different time points at follow up. In subset analysis of 23 patients 
who completed 6 months follow up general linear model was used for 
within the subject analysis of variances (ANOVA). p value <0.05 was 
considered statistically significant.  
Results: Forty patients undergoing adjuvant (n=26) and postoperative 
salvage (n=14) IMRT were included. At 3 months after completion of 
treatment, statistically significant improvement was observed across 
functional (except cognitive and social functioning) and symptom 
scales (except nausea and vomiting, dyspnoea, appetite loss and 
diarrhoea) when compared to pretreatment scores. Furthermore 
statistically significant improvement in global quality of life score 
(64.16 vs. 80.2,p=0.000). Amongst cervix specific QOL module (Cx-24) 
improvement in sexual and vaginal function was observed (85.93 vs. 
71, p=0.02). The difference in all other organ specific functional 
scores was not significant. However in symptom scale, reduction in 
